# Almitrine and COVID-19 Related Hypoxemia

> **NCT04380727** · — · COMPLETED · sponsor: **Central Hospital, Nancy, France** · enrollment: 17 (actual)

## Conditions studied

- COVID-19
- Hypoxic Respiratory Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04380727
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-20
- **Primary completion:** 2020-04-14
- **Final completion:** 2020-04-25
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2020-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04380727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04380727, "Almitrine and COVID-19 Related Hypoxemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04380727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*